USP24通过duebiquitinating和稳定TRAF2促进肝细胞癌瘤发生
Nana Zhou1, Chaoqin Guo1, Xiangyu Li2
1School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 310053, China.
Biochemical pharmacology
|August 10, 2024
概括
乌比基特异性酶24 (USP24) 通过稳定TRAF2和激活AKT/NF-κB信号,促进肝细胞癌 (HCC) 的生长. 抑制USP24可能会增强HCC免疫疗法的疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 乌比基因特异性化酶24 (USP24) 是一种参与瘤调节的二维基基因酶.
- 在肝细胞癌 (HCC) 中USP24的特定作用仍然在很大程度上未被描述.
研究的目的:
- 研究USP24在HCC发育和进展中的作用.
- 评估USP24作为HCC的潜在治疗点.
主要方法:
- 在HCC组织中USP24表达的分析和与预后的相关性.
- 在体外和体内实验中评估USP24对HCC细胞增殖和进展的影响.
- 研究涉及USP24,TRAF2和AKT/NF-κB通路的分子机制.
- 评估USP24,PD-L1表达和免疫逃避之间的关系.
- 评估USP24删除与抗PD-1疗法结合用于HCC免疫治疗.
主要成果:
- USP24在HCC组织中显著上调,并与患者预后不佳有关.
- USP24过度表达促进了HCC细胞增殖和瘤进展,无论是体外还是体内.
- USP24通过抑制其降解来稳定TRAF2,从而导致TRAF2的积累.
- 累积的TRAF2激活了AKT/NF-κB信号通路,提高了HCC细胞的存活率.
- USP24表达与HCC中的PD-L1水平正相关,这表明在免疫逃避中发挥了作用.
- USP24删除增强了CD8+ T细胞介导的瘤杀伤.
- 联合USP24删除和抗PD-1疗法改善了HCC免疫治疗结果.
结论:
- USP24在促进HCC的扩散,进展和免疫规避方面发挥着关键作用.
- USP24针对TRAF2,导致AKT/NF-κB通路激活和增强细胞存活.
- USP24抑制是抑制HCC生长的一个有希望的策略.
- 向USP24可能会增加HCC免疫疗法的疗效,特别是与检查点抑制剂结合使用.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
The Proteasome
819
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
819


